1. Barchukov VV, Tsorin IB, Likhosherstov AM, Vititnova MB, Mokrov GV, Gudasheva TA, Kryzhanovskii SA. Anti-Ischemic Activity of Triamine ALM-802 under Conditions of Endothelial Dysfunction. Bull. Exp. Biol. Med. 2019;167(4):460-463. https://doi.org/10.1007/s10517-019-04549-2
2. Barchukov VV, Tsorin IB, Likhosherstov AM, Vititnova MB, Mokrov GV, Kryzhanovskii SA. A comparative study of the anti-ischemic activity of trimetazidine and the compound ALM-802 under conditions of endothelial dysfunction. Farmakokinetika Farmakodinamika. 2019;(2):23-27. Russian
3. Kryzhanovskii SA, Likhosherstov AM, Tsorin IB, Stolyaruk VN, Vititnova MB, Mokrov GV, Gudasheva TA. Screening of the compounds having cardiotropic activity among the α, ω-diarilmetil derivatives of bis-(ω-aminoalkyl) amines. Farmakokinetika Farmakodinamika. 2016;(2):10-13. Russian.
4. Kryzhanovskii SA, Tsorin IB, Ionova EO, Stolyaruk VN, Vititnova MB, Barchukov VV, Miroshkina IA, Sorokina AV, Kozhevnikova LM, Durnev AD. A translational model of chronic heart failure in rats. Patol. Fiziol. Eksp. Ter. 2018;62(2):136-148. Russian.
5. Coats CJ, Pavlou M, Watkinson OT, Protonotarios A, Moss L, Hyland R, Rantell K, Pantazis AA, Tome M, McKenna WJ, Frenneaux MP, Omar R, Elliott PM. Effect of trimetazidine dihydrochloride therapy on exercise capacity in patients with nonobstructive hypertrophic cardiomyopathy: a randomized clinical trial. JAMA Cardiol. 2019;4(3):230-235. https://doi.org/10.1001/jamacardio.2018.4847